Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekDrug Channels ↗
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS…
The WeekDrug Channels ↗
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS…
The WeekSTAT News ↗
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effect…
The WeekAJMC ↗
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata…
The WeekBioPharma Dive ↗
The RNA-focused drugmaker says Inceptive's tools will help prioritize the best development options as well as …
The WeekFiercePharma ↗
In response to a planned healthcare reform initiative in Germany that would reduce the prices of branded drugs…
The WeekFierceBiotech ↗
Alnylam has partnered with the person who helped put the "T" in ChatGPT, paying $30 million to work with Jakob…
The WeekBriefing
Even before approval, Revolution Medicines’ pancreatic cancer asset is prompting discussion of how and when it…
The WeekSTAT News ↗
Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them …
The WeekBioPharma Dive ↗
Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients…
The WeekAJMC ↗
How Often Do Health Insurers Deny Doctor-Recommended Care?…
The WeekPharmaVoice ↗
As NASA prepares to bring its hallmark space lab back to Earth, a host of private companies are emerging to f…
The WeekFiercePharma ↗
For Meghan O'Hora, pharma marketing isn't about patients. It's about people and making real connections that h…
The WeekFierceBiotech ↗
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-r…
The WeekBriefing
The agency’s Complete Response Letter delays CTx‑1301, the biotech’s first commercial hopeful, over CMC issues…
The WeekSTAT News ↗
A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow…
The WeekAJMC ↗
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS…
The WeekBioPharma Dive ↗
Gedatolisib could "establish a new standard of care" for PIK3CA-mutated breast cancer, an investigator said, b…
The WeekFiercePharma ↗
Eisai has partnered with CaringKind to expand its nutrition support initiative to cover Alzheimer's disease an…
The WeekFierceBiotech ↗
Praxis Precision Medicines' epilepsy pipeline has suffered a setback after a next-gen NaV blocker failed to su…
The WeekBriefing
Obefazimod delivered industry-leading remission rates in ulcerative colitis, but new cancer cases wiped out th…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels Institute's latest exclusive analysis of…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels Institute's latest exclusive analysis of…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels Institute's latest exclusive analysis of…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.